Advanced glycation end products in hemodialysates as fluorescent and optical absorption markers of patients mortality

Hemodialysate (HD) samples collected from the end stage renal disease patients (ESRD Pts) were used for search for possible correlation between the intensity of HD visible auto-fluorescence (VF) detected at 420 nm as well as their optical absorption at 320 nm and the mortality events among the Pts. Previous but strongly promising correlations has been found in both cases which deserve further supplementation and examination. Investigation of possible influence of quenchers onto the VF intensity has been carried out. Endogenous inorganic ions present in biological fluids (serum, urine and HD) (Na, K, Ca, Mg and ammonia) do not affect the VF intensity remarkably but exogenous Al ions do that indirectly and specifically. Carbon based entities (nanoparticles of graphene type, humins) quench the VF effectively according to the Stern-Volmer law. The quenching phenomena and influence of aluminium must be taken into account by the further investigations, medical care and nutrition.

[1]  J. Schmitt,et al.  Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. , 2005, Analytical biochemistry.

[2]  S. Kuwajima,et al.  Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. , 1998, Metabolism: clinical and experimental.

[3]  E. Diamandis,et al.  Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. , 1994, Kidney international.

[4]  T. Meyer,et al.  New insights into uremic toxicity , 2008, Current opinion in nephrology and hypertension.

[5]  J. Schmitt,et al.  Characterization of advanced glycation end products: mass changes in correlation to side chain modifications. , 2005, Analytical biochemistry.

[6]  C. Wanner,et al.  Advanced glycation end products and mortality in hemodialysis patients. , 2002, Kidney international.

[7]  J. Fossey,et al.  Towards novel biolabels: synthesis of a tagged highly fluorescent Schiff-base aluminium complex , 2002 .

[8]  E G Lowrie,et al.  The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.

[9]  C. Choi,et al.  New regioisomeric naphthol–thiazole based ‘turn-on’ fluorescent chemosensor for Al3+ , 2013 .

[10]  Paul J Thornalley Advanced glycation end products in renal failure. , 2006, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[11]  A. Simm,et al.  Role of advanced glycation end products in cellular signaling , 2014, Redox biology.

[12]  A. Dawnay Renal clearance of glycation adducts: anti-glycation defence in uraemia and dialysis. , 2003, Biochemical Society transactions.

[13]  M. Ots-Rosenberg,et al.  Blue and UV fluorescence of biological fluids and carbon nanodots , 2013, Biophotonics-Riga.